At Pitney Bowes, Value-Based Insurance Design Cut Copayments And Increased Drug Adherence

摘要: To date, there has been little empirical evidence to support the broader use of value-based insurance design, which lowers copayments for services with high value relative their costs. address this lack data, we evaluated impact program a US corporation, Pitney Bowes. The eliminated cholesterol-lowering statins and reduced them clopidogrel, blood clot inhibitor. We found that policy was associated an immediate 2.8 percent increase in adherence controls, maintained subsequent year. For stabilizing rate four-percentage-point difference between intervention control subjects year later. Our study thus provides basis approach improve quality health care.